Matt Dellatorre

Stock Analyst at Goldman Sachs

(2.63)
# 1,991
Out of 5,129 analysts
5
Total ratings
100%
Success rate
33.87%
Average return

Stocks Rated by Matt Dellatorre

Teva Pharmaceutical Industries
Feb 9, 2026
Maintains: Buy
Price Target: $36$45
Current: $34.31
Upside: +31.16%
Viatris
Jun 6, 2025
Initiates: Neutral
Price Target: $10
Current: $16.13
Upside: -38.00%